Eric Benevich, Chief Commercial Officer: Neurocrine Biosciences NBIX Sell · Filed 24/04/17

Trade details

Type: Insider sale
Amount: $1,678,602.32
Shares · price: 12,587 sh · $133.36 a share
Held after: 40,778 sh
Stock: Neurocrine Biosciences NBIX
Person: Eric BenevichChief Commercial Officer
Trade date: 24/04/15
Filed: 24/04/17
Days to filing: 2 days

Sold 23.6% of holdings

Share of holding sold: 23.6%

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 24/03/16~24/05/15

Eric Benevich's recent trades

Eric BenevichOfficer
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$334.2K
2,154 sh
$334.2K
Filed 09/09
Traded 09/09
Eric BenevichChief Commercial Officer
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$905.9K
5,970 sh
$905.9K
Filed 25/12/02
Traded 25/11/28
Eric BenevichOfficer
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$904.9K
5,970 sh
$904.9K
Filed 25/11/28
Traded 25/11/28
Eric BenevichChief Commercial Officer
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$128.2K
1,098 sh
$128.2K
Filed 25/02/14
Traded 25/02/13
Eric BenevichChief Commercial Officer
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$123.2K
1,056 sh
$123.2K
Filed 25/02/14
Traded 25/02/13